Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

NCT06023459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Opioid-Related Disorders
Substance-Related Disorders
Narcotic-Related Disorders

Interventions

DRUG: Injectable extended-release buprenorphine
DRUG: Sublingual buprenorphine-naloxone

Sponsor

Yih-Ing Hser

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]